Keenova Therapeutics plc
MNKTQDelisted Sep 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567892
Keenova Therapeutics plc was delisted on Sep 6, 2023; its insiders filed their last Form 4 on Jul 23, 2026; 36 institutions reported holding it in 13F filings for Q2 2023, worth $12.4M in total; no superinvestor held it.
Holders of 5% or more of MNKTQ
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Keenova Therapeutics plc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Goldentree Asset Management LP | 13D | 20.20%7.95M shares | New | Aug 7, 20251 filing | Aug 7, 2025 | SEC |
| Silver Point Capital L.P. | 13D/A | 11.90%4.70M shares | +1.20 ppfrom 10.70% | Mar 18, 20253 filings | Dec 10, 2025 | SEC |
| Marathon Asset Management LP | 13G/A | 7.70%3.03M shares | – | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| Hudson Bay Capital Management LP | 13G/A | 6.30%2.48M shares | – | Aug 7, 20251 filing | Aug 7, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Keenova Therapeutics plc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 10, 20256:29 PM ET | Silver Point Capital L.P.and 2 others | 13D/A | 11.90%4.70M shares | +1.20 ppfrom 10.70% | Dec 8, 2025 | SEC |
| Nov 14, 20254:05 PM ET | Marathon Asset Management LPand 12 others | 13G/A | 7.70%3.03M shares | – | Sep 30, 2025 | SEC |
| Nov 5, 20257:58 PM ET | Silver Point Capital L.P.and 2 others | 13D/A | 10.70%4.21M shares | +2.10 ppfrom 8.60% | Nov 3, 2025 | SEC |
| Aug 7, 20254:50 PM ET | Goldentree Asset Management LPand 2 others | 13D | 20.20%7.95M shares | New | Jul 31, 2025 | SEC |
| Aug 7, 20252:11 PM ET | Hudson Bay Capital Management LPand 1 other | 13G/A | 6.30%2.48M shares | – | Jul 31, 2025 | SEC |
| Aug 4, 20254:52 PM ET | Hein Park Capital Management LPand 2 others | 13D/A | 4.90%1.96M shares | −4.79 ppfrom 9.69%Below 5% | Jul 31, 2025 | SEC |
| May 13, 20258:49 PM ET | Flynn James Eand 5 others | 13G/A | 4.07%804.3K shares | –Below 5% | Mar 31, 2025 | SEC |
| Mar 18, 20258:02 PM ET | Silver Point Capital L.P.and 2 others | 13D/A | 8.60%1.69M shares | – | Mar 13, 2025 | SEC |
| Mar 17, 20257:14 PM ET | Hein Park Capital Management LPand 2 others | 13D/A | 9.69%1.91M shares | – | Mar 13, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Keenova Therapeutics plc shares.
No Form 144 notices for Keenova Therapeutics plc are on file.